RankingsPricing
  1. US-listed companies
  2. AbbVie Inc.
  3. Financials
  4. Repurchases of common stock

AbbVie Inc.ABBV

Market cap
$417.4B
P/E ratio
SummaryFinancials
Period EndRepurchases of common stock (Million USD)YoY (%)
Dec 31, 20241,708-13.39%
Dec 31, 20231,972+32.62%
Dec 31, 20221,487+59.21%
Dec 31, 2021934-4.50%
Dec 31, 2020978+55.48%
Dec 31, 2019629-94.76%
Dec 31, 201812,014+752.06%
Dec 31, 20171,410-76.63%
Dec 31, 20166,033-20.27%
Dec 31, 20157,567+1060.58%
Dec 31, 2014652+103.75%
Dec 31, 2013320

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)